Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/06/2003EP1332213A2 55063, a human nmda family member and uses thereof
08/06/2003EP1332212A2 Proteins and nucleic acids encoding same
08/06/2003EP1332211A2 Human cytokine receptor
08/06/2003EP1332209A2 Collections of repeat proteins comprising repeat modules
08/06/2003EP1332207A2 Transformation systems for flavinogenic yeast
08/06/2003EP1332159A1 Process for the preparation of latent antithrombin iii
08/06/2003EP1332158A2 Peptides, the production and use thereof for binding immunoglobulins
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
08/06/2003EP1332155A2 Immunization of dairy cattle with gapc protein against streptococcus infection
08/06/2003EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp
08/06/2003EP1332153A1 Human ect2 and methods of use
08/06/2003EP1331949A2 Method for inducing apoptiosis
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331942A2 Immunogen comprising ligand bound hiv envelope protein
08/06/2003EP1241933A4 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight
08/06/2003EP1105051A4 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP1015570A4 Fibrin microbeads and uses thereof
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0970199A4 Fluorescent protein sensors for detection of analytes
08/06/2003EP0914148B1 Treatment of partial growth hormone insensitivity syndrome
08/06/2003EP0859959B1 Peptides which enhance transport across tissues and methods of identifying and using the same
08/06/2003EP0833943B1 Method for identifying secretory genes in helicobacter pylori
08/06/2003EP0791076A4 Diagnostic method and kit for determining kell blood group genotype
08/06/2003EP0788557A4 Rapid detection and identification of nucleic acid variants and pathogens
08/06/2003EP0687182B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/06/2003CN1434923A Conformational and topolodical protein regulation
08/06/2003CN1434921A T2R taste receptors and genes encoding same
08/06/2003CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/06/2003CN1434869A Root-specific promoter
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434863A Mutated BMP1B receptor as regulator of ovularion rate
08/06/2003CN1434862A Improvement of nucleic acid vaccination
08/06/2003CN1434859A Processes and organisms for the production of anti-freeze proteins
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434831A Improvments in or relating to immune responses to HIV
08/06/2003CN1434726A Multivalent platform molecules comprising high molecular weight polyethylene oxide
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434057A Process for preparing reversible photochromic biliprotein
08/06/2003CN1434056A Method for producing recombination human hepatitis B virus core antigen
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/06/2003CN1117145C Gene that imparts selective proliferative activity
08/06/2003CN1117099C Preparation of nerve growth factor
08/05/2003US6603063 Isolated polynucleotide that encodes a pesticidally active protein of given amino acid sequence
08/05/2003US6603058 Genetically modified mouse which results in absence of proopiomelanocortin peptide action, thereby showing a loss in body weight when treated peripherally with a melanocyte stimulating hormone agonist
08/05/2003US6603057 Disruption in genomic DNA fragment; tumorigenesis and propensity to ulcerative colitis; replacement with a neomycin gene under the control of phospholipid kinase; use in prevention and treatment of tumors; drug screening
08/05/2003US6602993 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases
08/05/2003US6602992 Isolated polynucleotide of the murine protein; hybridizes with the coding region of a mammalian nucleic acid; ears/biological
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602985 Extraction of zein protein from gluten meal
08/05/2003US6602983 Polypeptide and DNA sequence corresponding to human receptor with high affinity for IgE
08/05/2003US6602981 Antinociceptive agent derivative
08/05/2003US6602980 Of given sequence; useful for distinguishing between resorption of non-mineralized cartilage and mineralized cartilage; useful as immunogens and antigens
08/05/2003US6602979 Screening assays for compounds that cause apoptosis
08/05/2003US6602978 Polypeptide, of given amino acid sequence, specific for binding to a receptor; antibodies against the peptides are useful for enhancing or inhibiting inflammation and early effects of wound healing
08/05/2003US6602977 Receptor structures
08/05/2003US6602858 Ribozyme for use as tool in genetic engineering
08/05/2003US6602856 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602853 Antigenic peptides reacting with anti-ovary antibodies
08/05/2003US6602852 Basic peptides and pharmaceutical compositions containing same
08/05/2003US6602851 SMDF and GGF neuregulin splice variant isoforms and uses thereof
08/05/2003US6602850 Method of treating asthma using soluble IL-9 receptor variants
08/05/2003US6602849 Cyclic somatostatin analogs
08/05/2003US6602712 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602697 Process for purifying human papillomavirus virus-like particles
08/05/2003US6602694 Of given amino acid sequence; can use to treat conditions in which the regulation of thermogenesis is desired (obesity, diabetes, malignant hyperthermia, and fever)
08/05/2003US6602689 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602682 Kluyveromyces as a host strain
08/05/2003US6602672 Nucleic acid sequence; assay for distinguishing between conformational shapes and isolating infectious and noninfectious prions; neurodegenerative diseases; transgenic animals
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602519 Peptide factor used as replacement to steroid therapy; neutrophil migration stimulating activity; treating conditions associated with an inflammatory response of septic shock
08/05/2003US6602510 Eight isolated epitopes YLSGANLNV (SEQ ID NO:1), IMIGVLVGV (SEQ ID NO:2), KLBPVQLWV (SEQ ID NO:3), SMPPPGTRV (SEQ ID NO:4), KVAELVHFL (SEQ ID NO:5), YLQLVFGIEV (SEQ ID NO:6), RLLQETELV (SEQ ID NO:7), and, VVLGVVFGI (SEQ ID NO:8).
08/05/2003US6602509 Compound and method for the prevention and/or the treatment of allergy
08/05/2003US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
08/05/2003US6602507 Polypeptides from the conserved region of the M protein elicit a protective immune response against streptococcal infection
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
08/05/2003US6602504 Useful in prophylaxis, therapy, and diagnosis of infections in canines
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602500 Peptide antibiotic against Leptosphaeria, Micrococcus, Streptomyces, Escherichia; crops, canola
08/05/2003CA2228590C Cerebellum-derived growth factors, and uses related thereto
08/05/2003CA1341436C Synthetic antigens for the detection of aids-related disease caused by lav-2
07/2003
07/31/2003WO2003062830A2 Fibronectin variants and screening methods
07/31/2003WO2003062469A2 Gene matn3 or matrilin-3 linked to osteoarthritis treatment
07/31/2003WO2003062462A2 Method for isolating nucleic acids and protein from a single sample
07/31/2003WO2003062455A2 Zinc finger domain recognition code and uses thereof
07/31/2003WO2003062453A2 Polycystic kidney disease nucleic acids and proteins
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression